Search Results
Found 1 results
510(k) Data Aggregation
(62 days)
SPECTROLYSE HEPARIN (ANTI-IIA)
Spectrolyse® Heparin (anti-IIa) is intended for the quantitative determination of therapeutic heparin (standard and low molecular weight) in human plasma by anti-fl activity.
Not Found
This document is a 510(k) clearance letter from the FDA for a device called "Spectrolyse® Heparin (anti-IIa)". It is a regulatory approval document and does not contain the acceptance criteria or study details requested in the prompt. The letter only states that the device is substantially equivalent to legally marketed predicate devices and outlines the general regulatory requirements.
Therefore, I cannot provide the requested information based on the provided text.
Ask a specific question about this device
Page 1 of 1